40 results
8-K
EX-10.3
NXEN
Nexien Biopharma, Inc.
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
prior to such event (disregarding any limitation on exercise contained herein solely for the purpose of such determination). For purposes of any
8-K
EX-10.2
kjscg9
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
8-K
EX-10.1
umqn0mv
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
DEF 14C
n8k9ywt
8 Mar 19
Information statement
9:35am
8-K
EX-99.1
lxx1x4p 19ubsstdtc
26 Feb 19
Nexien BioPharma to File Pre-IND Meeting Request with the FDA
8:55am
8-K
EX-99.1
u3fe8jsv7tn c8j14dl
5 Nov 18
Regulation FD Disclosure
5:17pm
8-K
EX-99.1
nk2f1epx4k
30 Oct 18
Nexien BioPharma Acquires Princeton-Based CRx Bio and Announces Additions to Senior Management
6:18am
8-K
EX-99.1
pjm2akslsck10
19 Oct 18
Announces Symbol Change to NXEN
6:15am
8-K
EX-99.1
wt3n4wms
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
1:14pm